June 13, 2017
Drug Discovery News: Special Report on Cancer Metabolomics- Into the metabolic maelstrom
Learn More >>

March 27, 2017
BioWorld: Next-generation oncology: New technologies and MOAs
Learn More >>

March 24, 2017
BIOCENTURY: How Cornerstone’s CPI-613 leapfrogged to pivotal trials in AML and pancreatic cancer
Learn More >>

March 23, 2017
MedCity News: Cornerstone gets green light for two pivotal cancer trials
Learn More >>

March 17, 2017
PM 360 Movers and Shakers: Chi Van Dang, M.D., Ph.D., appointed to Cornerstone’s Board of Directors. Will also serve as Chair of its Scientific and Medical Advisory Boards
Learn More >>

February 14, 2017
WCTC-AM: Interview with Sanjeev Luther (COO, Cornerstone Pharmaceuticals)
Learn More >>

February 8, 2017
FirstWorld Pharma: Cornerstone Pharmaceuticals Announces the Addition of World-Renowned Experts to Scientific and Medical Advisory Boards
Learn More >>

January 30, 2017
BioWorld Appointments and Advancements:- Cornerstone’s new Board of Directors (Subscription Required)
Learn More >>

January 16, 2017
The Price of Business Radio: JP Morgan Biotech, Sanjeev Luther (COO, Cornerstone Pharmaceuticals) and Tim Pardee (Chief Oncologist, Cornerstone Pharmaceuticals) on CPI-613
Learn More >>

January 14, 2017
Vital Options International: Dr Timothy Pardee at ASH 2016- Addressing patients participating in clinical trials
Learn More >>

January 14, 2017
Vital Options International: Dr Timothy Pardee at ASH 2016- New Therapeutic Methods
Learn More >>

January 14, 2017
Vital Options International: Dr Zanetta Lamar at ASH 2016- The cost of therapy and quality of care
Learn More >>

January 14, 2017
Vital Options International: Dr Zanetta Lamar at ASH 2016- The data collected by Wake Forest Baptist Health
Learn More >>